首页> 外国专利> DIAGNOSIS AND MONITOR OF LUNG CANCER OF PATIENT WITH MEASUREMENT OF NCA50/90 IN BLOOD

DIAGNOSIS AND MONITOR OF LUNG CANCER OF PATIENT WITH MEASUREMENT OF NCA50/90 IN BLOOD

机译:NCA50 / 90在血液中的诊断与监测。

摘要

PURPOSE: To assist disgnosis of lung cancer by using an index for such cancer consisting of existence of a level at which the nonpeculiar crossing reaction antigen(NCA) 50/90 in the blood of a patient has increased significantly. ;CONSTITUTION: An antigen NCA 50/90 increases significantly in the blood of a patient suffering from lung cancer. The NCA 50/90 content of a blood specimen sampled from any person exhibiting an indication of lung cancer is measured and compared with the mean of NCA 50/90 in the normal population. Existence of the quantity level at which the NCA 50/90 content of the blood has increased significantly, is used as the index for lung cancer having propagated in the patient. This serves diagnosis of a patient exhibiting an indication of lung cancer, and a doctor uses it in diagnosis along with other information implying his suffering from lung cancer. An increment of blood NCA 50/90 level for a certain period shows usually a situation of worsening, while a sink of the blood NCA 50/90 level shows situation that the decease situation has improved.;COPYRIGHT: (C)1994,JPO
机译:目的:通过使用这样的癌症指数来辅助肺癌的诊断,该指数包括患者血液中非特殊交叉反应抗原(NCA)50/90的水平显着增加。组成:抗原NCA 50/90在患有肺癌的患者的血液中显着增加。测量从表现出肺癌迹象的任何人采集的血液样本中NCA 50/90的含量,并将其与正常人群中NCA 50/90的平均值进行比较。血液中NCA 50/90含量显着增加的量水平的存在被用作已在患者中传播的肺癌的指标。这可用于诊断患有肺癌迹象的患者,医生可将其与其他暗示他患有肺癌的信息一起用于诊断。一定时期内血液NCA 50/90水平的升高通常表明情况恶化,而血液NCA 50/90水平下降则表明病情有所改善。;版权所有:(C)1994,JPO

著录项

  • 公开/公告号JPH06324045A

    专利类型

  • 公开/公告日1994-11-25

    原文格式PDF

  • 申请/专利权人 MILES INC;

    申请/专利号JP19940104404

  • 发明设计人 ALLARD WILLIAM JEFFREY;YEUNG KWOK K;

    申请日1994-04-20

  • 分类号G01N33/574;G01N33/53;

  • 国家 JP

  • 入库时间 2022-08-22 04:22:47

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号